Regardless of the global progress in early diagnosis and novel therapeutic regimens, breast
carcinoma poses a devastating threat, and the advances are somewhat marred by high …

Dysregulated epigenetic modifications dynamically drive the abnormal transcription process
to affect the tumor microenvironment; thus, promoting cancer progression, drug resistance …

Simple Summary Breast cancer (BC) is the most common cancer diagnosed among women
worldwide. Despite numerous studies, the pathogenesis of BC is still poorly understood, and …

The microbiota plays essential roles in health and disease, in both the intestine and the
extra-intestine. Dysbiosis of the gut microbiota causes dysfunction in the intestine, which …

The global burden of breast cancer (BC) is increasing significantly. This trend is caused by
several factors such as late diagnosis, limited treatment options for certain BC subtypes …

Women with the breast cancer type 1 susceptibility protein (BRCA1) mutation and loss of
BRCA1 expression are reported to have an increased risk of triple‐negative breast cancer …

Extensive research into prodrug modification of active pharmaceutical ingredients and
nanoparticle drug delivery systems has led to unprecedented levels of control over the …

Breast cancer (BC) is the most common cancer in women in the United States. There has
been an increasing incidence and decreasing mortality rate of BC cases over the past …

Recent evidence suggests that autophagy is a governed catabolic framework enabling the
recycling of nutrients from injured organelles and other cellular constituents via a lysosomal …

Emerging evidence suggests a profound association between the microbiota composition in
the gastrointestinal tract and breast cancer progression. The gut microbiota plays a crucial …